Distinct Lipidomic Landscapes Associated with Clinical Stages of Urothelial Cancer of the Bladder

European Urology Focus - Tập 4 - Trang 907-915 - 2018
Danthasinghe Waduge Badrajee Piyarathna1, Thekkelnaycke M. Rajendiran2,3, Vasanta Putluri4, Venkatrao Vantaku1, Tanu Soni3, Friedrich-Carl von Rundstedt5,6, Sri Ramya Donepudi4, Feng Jin4, Suman Maity4, Chandrashekar R. Ambati4, Jianrong Dong1, Daniel Gödde7, Stephan Roth8, Stephan Störkel7, Stephan Degener8, George Michailidis9, Seth P. Lerner5, Subramaniam Pennathur10, Yair Lotan11, Cristian Coarfa1,4
1Department of Molecular and Cell Biology, Baylor College of Medicine, Houston, TX, USA
2Department of Pathology, Michigan Regional Comprehensive Metabolomics Resource Core, Ann Arbor, Michigan, USA
3Division of Bioinformatics, Michigan Regional Comprehensive Metabolomics Resource Core, Ann Arbor, Michigan, USA
4Dan L. Duncan Cancer Center, Advanced Technology Core, Alkek Center for Molecular Discovery, Baylor College of Medicine, Houston, TX, USA
5Scott Department of Urology, Baylor College of Medicine, Houston, TX, USA
6Department of Urology, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany
7Department of Pathology, Witten-Herdecke University, Wuppertal, Germany
8Department of Urology Helios Klinikum, Witten-Herdecke University, Wuppertal, Germany
9Department of Statistics, University of Florida, Gainesville, FL, USA
10Division of Nephrology, Department of Medicine, University of Michigan, Ann Arbor MI 48015
11Department of Urology, University of Texas Southwestern, Dallas, TX, USA

Tài liệu tham khảo

Andreassen, 2016, Incidence and survival of urothelial carcinoma of the urinary bladder in Norway 1981–2014, BMC Cancer, 16, 799, 10.1186/s12885-016-2832-x Maffezzini M. Re: Richard J. Sylvester, Adrian P.M. van der Meijden, Willem Oosterlinck, J. Alfred Witjes, Christian Bouffioux, Louis Denis and Donald W.W. Newling. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006;49:466–77. Eur Urol 2006;50:623–4; author reply 624–5. Teasdale, 1993, Cryopreservation of cultured dermal fibroblast impregnated collagen gels, Burns, 19, 406, 10.1016/0305-4179(93)90062-D Alo, 1996, Expression of fatty acid synthase (FAS) as a predictor of recurrence in stage I breast carcinoma patients, Cancer, 77, 474, 10.1002/(SICI)1097-0142(19960201)77:3<474::AID-CNCR8>3.0.CO;2-K Alo, 1999, Fatty acid synthase (FAS) predictive strength in poorly differentiated early breast carcinomas, Tumori, 85, 35, 10.1177/030089169908500108 Epstein, 1995, OA-519 (fatty acid synthase) as an independent predictor of pathologic state in adenocarcinoma of the prostate, Urology, 45, 81, 10.1016/S0090-4295(95)96904-7 Rashid, 1997, Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia, Am J Pathol, 150, 201 Gansler, 1997, Increased expression of fatty acid synthase (OA-519) in ovarian neoplasms predicts shorter survival, Hum Pathol, 28, 686, 10.1016/S0046-8177(97)90177-5 Sharma, 2016, Chemotherapy agents alter plasma lipids in breast cancer patients and show differential effects on lipid metabolism genes in liver cells, PLoS One, 11, e0148049, 10.1371/journal.pone.0148049 Han, 2016, Lipidomics for studying metabolism, Nat Rev Endocrinol, 12, 668, 10.1038/nrendo.2016.98 Pietilainen, 2007, Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects—a monozygotic twin study, PLoS One, 2, e218, 10.1371/journal.pone.0000218 Han, 2007, Alterations in myocardial cardiolipin content and composition occur at the very earliest stages of diabetes: a shotgun lipidomics study, Biochemistry, 46, 6417, 10.1021/bi7004015 Zhou, 2012, Identification of plasma lipid biomarkers for prostate cancer by lipidomics and bioinformatics, PLoS One, 7, e48889, 10.1371/journal.pone.0048889 Balogh, 2010, Lipidomics reveals membrane lipid remodelling and release of potential lipid mediators during early stress responses in a murine melanoma cell line, Biochim Biophys Acta, 1801, 1036, 10.1016/j.bbalip.2010.04.011 Gorke, 2010, Determining and interpreting correlations in lipidomic networks found in glioblastoma cells, BMC Syst Biol, 4, 126, 10.1186/1752-0509-4-126 Cancer Genome Atlas Research Network, 2014, Comprehensive molecular characterization of urothelial bladder carcinoma, Nature, 507, 315, 10.1038/nature12965 Kim, 2010, Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer, Mol Cancer, 9, 3, 10.1186/1476-4598-9-3 Slebe, 2016, FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth, Nat Commun, 7, 11199, 10.1038/ncomms11199 Trousil, 2014, Alterations of choline phospholipid metabolism in endometrial cancer are caused by choline kinase alpha overexpression and a hyperactivated deacylation pathway, Cancer Res, 74, 6867, 10.1158/0008-5472.CAN-13-2409 Fan, 2015, AGPAT9 suppresses cell growth, invasion and metastasis by counteracting acidic tumor microenvironment through KLF4/LASS2/V-ATPase signaling pathway in breast cancer, Oncotarget, 6, 18406, 10.18632/oncotarget.4074 Jiang, 2013, Involvement of TRPC channels in lung cancer cell differentiation and the correlation analysis in human non-small cell lung cancer, PLoS One, 8, e67637, 10.1371/journal.pone.0067637 Hilvo, 2011, Novel theranostic opportunities offered by characterization of altered membrane lipid metabolism in breast cancer progression, Cancer Res, 71, 3236, 10.1158/0008-5472.CAN-10-3894 Biton, 2014, Independent component analysis uncovers the landscape of the bladder tumor transcriptome and reveals insights into luminal and basal subtypes, Cell Rep, 9, 1235, 10.1016/j.celrep.2014.10.035 Seth, 2012, Lipid profiles and the risk of endometrial cancer in the Swedish AMORIS study, Int J Mol Epidemiol Genet, 3, 122